Drug Profile
Tiqueside
Alternative Names: CP 88818; Tigogenin cellobiosideLatest Information Update: 15 Feb 1995
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antihyperglycaemics; Antihyperlipidaemics
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercholesterolaemia
Most Recent Events
- 15 Feb 1995 Discontinued-Preclinical for Hypercholesterolaemia in USA (Unknown route)